Moreover, when developed subcutaneously, tumor induced the deposition of a CCR2 ligand, CCL2 inside IVRs, resulting in the enhancement of antigen uptake by intrathymic Sirpα+ cDCs. Here, SIRPA is linked to neoplasm.